Clinical performance of PHI for predicting prostate cancer in obese men

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|115|4|537-545

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.115, Iss.4, 2015-04, pp. : 537-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2990-2998

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 4052-4053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 4053-4054

John Wiley & Sons Inc

Access to resources Recommend Favorite

In‐parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 527-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer

By  

Urologia Internationalis, Vol. 99, Iss. 2, 2017-03 ,pp. : 207-214

Karger

Access to resources Recommend Favorite